Category: Feature Stories

Caritas President Michael Landau has made an appeal for social cohesion and confidence in the face of the Corona crisis, the recent lockdown and the Islamist terrorist attack in Vienna. “Charity does not go into the lockdown”, said Landau during a service on Sunday in St. Stephen’s Cathedral on the occasion of the church’s “World Day of the Poor”. The willingness to stand together, to tackle and not to forget the weakest had made Austria great in the past, the Caritas President stressed. “We should continue on this path in…

Read More

The number of confirmed coronavirus infections in the EU and other European countries has doubled to more than ten million within only three and a half weeks. By Friday, a total of 10,124,110 cases had been reported in the European Economic Area including the UK. This is almost 242,000 more than the day before. It was only on October 20 that the mark of five million proven infections was exceeded.According to the daily survey of the European Centre for Disease Prevention and Control (ECDC), most infections have now been registered…

Read More

The news about a new corona vaccine gives hope. How does it work? And when could it be used in Austria? We get to the bottom of the most important questions. What is known about the effect of the vaccine so far?According to the German company Biontech and the pharmaceutical company Pfizer, the vaccine candidate BNT162b2 is said to offer a 90 percent protection rate. Serious side effects have not been registered to date. This information is based on interim results of the Phase 3 study, which is crucial for…

Read More

Corona. Lockdown. All over again? Not quite, but the newly imposed lockdown light is still a huge psychological blow to all of us. When the Corona pandemic brought everything to a standstill in the spring, the summer was full of rays of hope. And it gave us courage. Now not only are all restaurants, bars and museums closing again, but we are also facing the darkest, dimmest and longest season of the year. A low mood or even depression is pre-programmed. Corona Lockdown light: How it affects the psycheGeneral frustration…

Read More

Following the supply agreement between the EU and the pharmaceutical companies BioNTech and Pfizer, Health Minister Rudolf Anschober (Greens) is optimistic that it will be possible to vaccinate risk groups and health workers against the coronavirus in the first quarter of 2021. “I assume that the other interested population can then be vaccinated step by step from the second quarter onwards. We are currently preparing the vaccination logistics for this,” he explained in a press release on Wednesday. The Ministry of Health has emphasized that the vaccination should first be…

Read More

A novel vaccination is to provide 90 percent protection against the coronavirus. The pharmaceutical companies Pfizer and Biontech have developed a vaccine that is expected to offer 90 percent protection against corona disease. It has already been tested on 43,500 people. One of them is the Austrian virologist and top researcher Florian Krammer. He cheered: “For the first time we are seeing a vaccine that works. The vaccine uses a completely experimental approach, which involves injecting part of the virus’s genetic code into people, in order to train the immune…

Read More

About 54 percent of the Austrians would be vaccinated against COVID-19, should there be a vaccine. This is the result of a representative online survey conducted by GfK among 1,005 participants between the end of September and the beginning of October. Almost half of the respondents stated that they had been psychologically stressed by the initial restrictions. However, this situation had improved after the end of the lockdown, the results were presented. “2020 is a very challenging year. None of us would have known in January how the following ten…

Read More

An effective corona vaccine in Europe and the USA is within reach: On Monday, the Mainz-based company Biontech and the pharmaceutical company Pfizer were the first Western manufacturers to publish promising results of a study that is crucial for approval.For the first time, interim results from the study phase, which is crucial for approval, have been published for a corona vaccine that is crucial for Europe. According to these data, the Mainz-based pharmaceutical company Biontech announced on Monday that its vaccine offers more than 90 percent protection against the disease…

Read More

Frankfurt/New York, Nov 09 (Reuters) – The Mainz-based biotech company BioNTech is close to a breakthrough with its potential corona vaccine. BioNTech and its US partner Pfizer presented positive efficacy data from the pivotal study with the vaccine on Monday. According to these data, the risk of contracting Covid-19 was more than 90 percent lower for study participants who received the vaccine than without the vaccination. BioNTech and Pfizer are thus the first companies worldwide to present successful data from the study with a corona vaccine, which is crucial for…

Read More